Back

How to report cardiovascular side effects: practical guidance

19 June 2026 (08:40 - 08:50)
Organised by: Logo
Congress Presentation Part of: Cardio-onco pharmacology: expanding the multidisciplinary team and facing new challenges Cardio-Oncology CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Charles Dolladille

University Hospital of Caen, Caen (France)

3 More presentations in this session

Presentation thumbnail
General principles of drug–drug interactions in cardio-oncology
Doctor B. Aretin (Vienna, AT)
Slides
Presentation thumbnail
QT prolongation in cardio-oncology: understanding the risk
Doctor M. Fradley (Philadelphia, US)
Slides
Presentation thumbnail
Cardio-Onco Pharmacology: expanding the multidisciplinary team and facing new challenges - discussion

Access the full session

Session thumbnail
Cardio-onco pharmacology: expanding the multidisciplinary team and facing new challenges
Video

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 08:40 CET
You may be interested in
thumbnail
Webinar
How to organise cardiovascular monitoring during cancer treatment: who, when and how. ESC 2022 Clinical Practice Guidelines - Webinar Series
26 September 2022
thumbnail
Congress Presentation
Cardiovascular toxicities reported with Poly ADP Ribose Polymerase (PARP) inhibitors in the FDA Adverse Event Reporting System
21 June 2025
thumbnail
Congress Presentation
Class-level differences and within-class heterogeneity in heart failure reporting with immune checkpoint inhibitors: a WHO vigiaccess pharmacovigilance study
9 May 2026
thumbnail
Webinar
Personalised CVD prevention: the evidence behind the current guidelines. ESC 2021 Clinical Practice Guidelines - Webinar Series
23 June 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources